By 2006, researchers had identified a few so-called "broadly neutralizing antibodies" (bNAbs) that worked on multiple HIV strains.
En 2006, os investigadores identificaron algúns que foron chamados anticorpos amplamente neutralizantes (bNAb) que funcionaban sobre múltiples cepas do VIH.